|
| Wednesday, November 5, 2014 |
|
|
Omnicare Specialty Care Group to Provide Specialty Support Services for New Treatment for IPF - OFEV (nintedanib) |
| RxCrossroads and Advanced Care Scripts (ACS), both divisions of Omnicare Specialty Care Group (SCG), announced today that they have been selected to provide services for patients prescribed Boehringer Ingelheim's OFEV(R) capsules (nintedanib). more info >> |
|
| Thursday, October 30, 2014 |
|
|
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest |
| Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest more info >> |
|
| Saturday, October 25, 2014 |
|
|
Omnicare Reports Third-Quarter 2014 Financial Results; Company Updates Full-Year 2014 Guidance |
| Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2014. more info >> |
|
| Wednesday, October 1, 2014 |
|
|
Omnicare to Report Third-Quarter 2014 Financial Results and Hold Conference Call on Friday, October 24, 2014 |
| Omnicare, Inc. (NYSE:OCR) will release its financial results for the third-quarter of fiscal 2014 before the market opens on Friday, October 24, 2014. more info >> |
|
| Tuesday, September 23, 2014 |
|
|
Ashok Singh to Join Omnicare as SVP, Chief Information Officer |
| Omnicare, Inc. (NYSE: OCR) today announced Ashok Singh has been appointed Senior Vice President, Chief Information Officer (CIO) effective October 1, 2014. more info >> |
|
| Friday, September 12, 2014 |
|
|
Omnicare Declares Quarterly Cash Dividend |
| Omnicare, Inc. (NYSE:OCR), today announced that its Board of Directors has approved a quarterly cash dividend of $0.20 per share on the Company's common stock, to be paid on September 29, 2014, to all stockholders of record on September 22, 2014. more info >> |
|
| Thursday, July 24, 2014 |
|
|
Omnicare Reports Second-Quarter 2014 Financial Results |
| Omnicare, Inc. (NYSE:OCR) reported today financial results for its second-quarter ended June 30, 2014. more info >> |
|
| Tuesday, July 8, 2014 |
|
|
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest |
| Omnicare, Inc. (NYSE: OCR) announced today that for the period from June 15, 2014 to September 14, 2014 its Series A and Series B Trust Preferred Income Equity Redeemable Securities will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended June 12, 2014. more info >> |
|
| Wednesday, July 2, 2014 |
|
|
Omnicare to Report Second-Quarter 2014 Financial Results and Hold Conference Call on Wednesday, July 23, 2014 |
| Omnicare, Inc. (NYSE:OCR) will release its financial results for the second-quarter of fiscal 2014 before the market opens on Wednesday, July 23, 2014. more info >> |
|
| Wednesday, June 11, 2014 |
|
|
Advanced Care Scripts to Provide Specialty Pharmacy Services for Otezla(R) (apremilast) |
| Advanced Care Scripts (ACS), a division of Omnicare Specialty Care Group (SCG), announced today that it has been added to the limited distribution network for Celgene's Otezla(R) (apremilast). more info >> |
|
|
|
|
